| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bias in genotyping the miR-27a rs895819 and rs11671784 variants
|
Yang, Rongxi
|
|
2012
|
134 |
2 |
p. 899-901
|
artikel
|
| 2 |
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
|
Murphy, Caitlin C.
|
|
2012
|
134 |
2 |
p. 459-478
|
artikel
|
| 3 |
Adjuvant bisphosphonate treatment for breast cancer: Why did something so elegant become so complicated?
|
Clemons, Mark
|
|
2012
|
134 |
2 |
p. 453-457
|
artikel
|
| 4 |
Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease
|
Su, Xuefen
|
|
2012
|
134 |
2 |
p. 783-791
|
artikel
|
| 5 |
Adult weight gain, fat distribution and mammographic density in Spanish pre- and post-menopausal women (DDM-Spain)
|
Pollán, Marina
|
|
2012
|
134 |
2 |
p. 823-838
|
artikel
|
| 6 |
AKT-aro and HER2-aro, models for de novo resistance to aromatase inhibitors; molecular characterization and inhibitor response studies
|
Wong, Cynthie
|
|
2012
|
134 |
2 |
p. 671-681
|
artikel
|
| 7 |
Analysis of KLLN as a high-penetrance breast cancer predisposition gene
|
Thompson, Ella R.
|
|
2012
|
134 |
2 |
p. 543-547
|
artikel
|
| 8 |
Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program
|
Bilous, Michael
|
|
2012
|
134 |
2 |
p. 617-624
|
artikel
|
| 9 |
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis
|
Niraula, Saroj
|
|
2012
|
134 |
2 |
p. 769-781
|
artikel
|
| 10 |
Differential anti-proliferative activities of poly(ADP-ribose) polymerase (PARP) inhibitors in triple-negative breast cancer cells
|
Chuang, Hsiao-Ching
|
|
2012
|
134 |
2 |
p. 649-659
|
artikel
|
| 11 |
Early breast cancer with positive margins: excellent local control with an upfront brachytherapy boost
|
Schroeder, Thomas M.
|
|
2012
|
134 |
2 |
p. 719-725
|
artikel
|
| 12 |
Estrogen receptor beta binds Sp1 and recruits a corepressor complex to the estrogen receptor alpha gene promoter
|
Bartella, V.
|
|
2012
|
134 |
2 |
p. 569-581
|
artikel
|
| 13 |
Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among black and white women
|
Reding, Kerryn W.
|
|
2012
|
134 |
2 |
p. 801-809
|
artikel
|
| 14 |
Expression of activated type I receptor tyrosine kinases in early breast cancer
|
Spears, Melanie
|
|
2012
|
134 |
2 |
p. 701-708
|
artikel
|
| 15 |
Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer
|
Alshareeda, Alaa T.
|
|
2012
|
134 |
2 |
p. 519-529
|
artikel
|
| 16 |
Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer
|
Cescon, David W.
|
|
2012
|
134 |
2 |
p. 759-767
|
artikel
|
| 17 |
Fruits, vegetables and breast cancer risk: a systematic review and meta-analysis of prospective studies
|
Aune, D.
|
|
2012
|
134 |
2 |
p. 479-493
|
artikel
|
| 18 |
HER-2 gene amplification by fluorescence in situ hybridization (FISH) compared with immunohistochemistry (IHC) in breast cancer: a study of 528 equivocal cases
|
Zhang, Han
|
|
2012
|
134 |
2 |
p. 743-749
|
artikel
|
| 19 |
High sensitivity for BRCA1/2 mutations in breast/ovarian kindreds: are there still other breast/ovary genes to be discovered?
|
Smith, Miriam J.
|
|
2012
|
134 |
2 |
p. 895-897
|
artikel
|
| 20 |
Incidence of invasive breast cancer in the presence of competing mortality: the Canadian National Breast Screening Study
|
Taghipour, Sharareh
|
|
2012
|
134 |
2 |
p. 839-851
|
artikel
|
| 21 |
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy
|
Jacot, William
|
|
2012
|
134 |
2 |
p. 709-717
|
artikel
|
| 22 |
Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option
|
Pessetto, Ziyan Yuan
|
|
2012
|
134 |
2 |
p. 511-517
|
artikel
|
| 23 |
Long-term survival of older breast cancer patients: population-based estimates over three decades
|
Kanapuru, Bindu
|
|
2012
|
134 |
2 |
p. 853-857
|
artikel
|
| 24 |
Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients
|
Tang, Jun
|
|
2012
|
134 |
2 |
p. 549-560
|
artikel
|
| 25 |
Mechanisms of cardiotoxicity associated with ErbB2 inhibitors
|
Fedele, Carmine
|
|
2012
|
134 |
2 |
p. 595-602
|
artikel
|
| 26 |
NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup
|
Retsky, Michael
|
|
2012
|
134 |
2 |
p. 881-888
|
artikel
|
| 27 |
Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells
|
Debeb, Bisrat G.
|
|
2012
|
134 |
2 |
p. 495-510
|
artikel
|
| 28 |
Predictions of the pathological response to neoadjuvant chemotherapy in patients with primary breast cancer using a data mining technique
|
Takada, M.
|
|
2012
|
134 |
2 |
p. 661-670
|
artikel
|
| 29 |
Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer
|
Sandberg, Maria E. C.
|
|
2012
|
134 |
2 |
p. 793-800
|
artikel
|
| 30 |
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study
|
Solin, Lawrence J.
|
|
2012
|
134 |
2 |
p. 683-692
|
artikel
|
| 31 |
Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer
|
Grob, Tobias J.
|
|
2012
|
134 |
2 |
p. 561-567
|
artikel
|
| 32 |
Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry
|
Zhang, Jing
|
|
2012
|
134 |
2 |
p. 889-894
|
artikel
|
| 33 |
Sentinel lymph node biopsy of the internal mammary chain in breast cancer
|
Postma, E. L.
|
|
2012
|
134 |
2 |
p. 735-741
|
artikel
|
| 34 |
Serum cotinine and prognosis in breast cancer
|
Johnson, L.
|
|
2012
|
134 |
2 |
p. 811-814
|
artikel
|
| 35 |
SGK3 is associated with estrogen receptor expression in breast cancer
|
Xu, Jun
|
|
2012
|
134 |
2 |
p. 531-541
|
artikel
|
| 36 |
Specific transcriptional response of four blockers of estrogen receptors on estradiol-modulated genes in the mouse mammary gland
|
Calvo, Ezequiel
|
|
2012
|
134 |
2 |
p. 625-647
|
artikel
|
| 37 |
The economic burden of metastatic breast cancer: a U.S. managed care perspective
|
Montero, Alberto J.
|
|
2012
|
134 |
2 |
p. 815-822
|
artikel
|
| 38 |
The influence of mammographic density on breast tumor characteristics
|
Eriksson, Louise
|
|
2012
|
134 |
2 |
p. 859-866
|
artikel
|
| 39 |
The influence of non-clinical patient factors on medical oncologists’ decisions to recommend breast cancer adjuvant chemotherapy
|
Pini, T. May
|
|
2012
|
134 |
2 |
p. 867-874
|
artikel
|
| 40 |
Therapeutic potential for phenytoin: targeting Nav1.5 sodium channels to reduce migration and invasion in metastatic breast cancer
|
Yang, Ming
|
|
2012
|
134 |
2 |
p. 603-615
|
artikel
|
| 41 |
Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide
|
Gjerde, Jennifer
|
|
2012
|
134 |
2 |
p. 693-700
|
artikel
|
| 42 |
TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer
|
Sparano, Joseph A.
|
|
2012
|
134 |
2 |
p. 751-757
|
artikel
|
| 43 |
Upregulation of mucin4 in ER-positive/HER2-overexpressing breast cancer xenografts with acquired resistance to endocrine and HER2-targeted therapies
|
Chen, Albert C.
|
|
2012
|
134 |
2 |
p. 583-593
|
artikel
|
| 44 |
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010
|
Waters, Erika A.
|
|
2012
|
134 |
2 |
p. 875-880
|
artikel
|
| 45 |
Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer
|
Sestak, Ivana
|
|
2012
|
134 |
2 |
p. 727-734
|
artikel
|
Tijdschrift beschrijving